Infection prevention and control Annette Jeanes Director of - PowerPoint PPT Presentation

Infection prevention and control Annette Jeanes Director of Infection Prevention and Control and Consultant nurse

Summary  History of infection prevention and control  National issues  UCLH  Future

Infection Control

What is infection prevention and control?  Prevention of acquisition and transmission of infection  Detection and investigation including contact tracing  Surveillance and monitoring  Teaching and training  Planning services and buildings  Outbreak management and control  Generating new knowledge  Expert advice

Its not rocket science  Hand hygiene  Isolation of infectious patients  Screening and monitoring  Clean patient  Clean environment  Ventilation and water  Immunisation  Nutrition and hydration

What it isn't

9

10

11

Invisible support service  Team including laboratories  >40 new referrals to the reactive nurse desk each day  On call service every day/24 hours/throughout the year  Requests for information  Reports and responses  Meetings  Contract tracing  Investigations  Staff are our main clients

National picture  Legislation  Regulation and monitoring  Guidelines and standards  Targets  Reduction in MRSA bacteraemia  Reduction in Clostridium difficile  Ebola  Influenza  Antibiotic stewardship  Carbapenem resistant organisms (CRO)

14

Current UCLH IPC challenges (examples)  Vulnerable patients  Fast throughput including day surgery  Mixing of patient groups  Patients and visitors travelling long distances  Highly specialist services  Getting the basics right  Information  Cleaning  Isolation  Invasive devices  Hand hygiene

Healthcare associated infections 16

17

18

19

20

21

22

23

Human factors 24

25

The future  Antibiotic resistance  New micro-organisms particularly gram negatives and virus  Increasing susceptibility particularly the very young and very old  Staffing, training and knowledge  Cleaning and disinfection  Hand hygiene  Involvement and engagement of patients and public

27